Lv Ming-Yi, Deng Shu-Ling, Long Xiao-Feng, Liu Zeng-Liang
a Department of Internal Medicine , ICU, Affiliated Zhongshan Hospital of Dalian University , Dalian , Liaoning Province , P.R. China.
b Department of Neurosurgery , The Second Affiliated Hospital, Qiqihar Medical College , Qiqihar , P.R. China.
Br J Neurosurg. 2017 Jun;31(3):322-326. doi: 10.1080/02688697.2017.1297368. Epub 2017 Mar 13.
To investigate the long term outcomes of microvascular decompression (MVD) for hemifacial spasm (HFS) and to identify any prognostic factors.
A retrospective analysis of 189 consecutive patients with typical HFS who underwent MVD. Multiple logistic regression analysis of variables at various time points including at least immediate time point and one at no less than six years was performed.
Short-term follow-up showed a cure rate of 91%, including 51 cases of delayed resolution (27%). At two years or more information was available in 148 (out of 189) cases of patients. 101 cases (68% - of 148 cases) had complete recovery, 28 cases (19%) achieved a partial though worthwhile recovery, so that the effective rate of symptoms relief at six years was 87%. Complications were found (66/189, 34.92%) and cured within the follow-up period (cure rate of 100%). In both the univariate and multivariate analyses, the postoperative findings of clinical outcomes showed that preoperative illness duration, compressive pattern, the intraoperative indentation of the root exit zone (REZ) of the facial nerve and intraoperative AMR disappearance were negative predictors and age considered to be positive, which significantly predicted the clinical outcome of patients following MVD.
MVD may be a safe and effective strategy for HFS patients in view of relatively higher cure rates and lower complication risks within follow-up. Besides, patients' age, duration of disease, intraoperative indentation of the REZ of the facial nerve, and disappearance of AMR were the major influential variables may be useful for the prediction of prognosis in the patients underwent MVD.
探讨微血管减压术(MVD)治疗面肌痉挛(HFS)的长期疗效,并确定任何预后因素。
对189例连续接受MVD治疗的典型HFS患者进行回顾性分析。对包括至少即时时间点和一个不少于六年时间点的不同时间点的变量进行多因素逻辑回归分析。
短期随访显示治愈率为91%,包括51例延迟缓解(27%)。在189例患者中,有148例患者在两年或更长时间有可用信息。101例(148例中的68%)完全恢复,28例(19%)虽部分恢复但有价值,因此六年时症状缓解有效率为87%。发现并发症(66/189,34.92%)并在随访期内治愈(治愈率100%)。在单因素和多因素分析中,临床结局的术后结果均显示,术前病程、压迫模式、面神经根部出口区(REZ)术中压痕和术中肌电图反应(AMR)消失是阴性预测因素,而年龄被认为是阳性预测因素,它们显著预测了MVD术后患者的临床结局。
鉴于随访期间相对较高的治愈率和较低的并发症风险,MVD可能是HFS患者的一种安全有效的治疗策略。此外,患者年龄、病程、面神经REZ术中压痕以及AMR消失是主要影响变量,可能有助于预测接受MVD治疗患者的预后。